- -

Controlled Synthesis of Up-Conversion NaYF4:Yb,Tm Nanoparticles for Drug Release under Near IR-Light Therapy

RiuNet: Repositorio Institucional de la Universidad Politécnica de Valencia

Compartir/Enviar a

Citas

Estadísticas

  • Estadisticas de Uso

Controlled Synthesis of Up-Conversion NaYF4:Yb,Tm Nanoparticles for Drug Release under Near IR-Light Therapy

Mostrar el registro sencillo del ítem

Ficheros en el ítem

dc.contributor.author Moyano Rodríguez, Edelweiss es_ES
dc.contributor.author Gomez-Mendoza, Miguel es_ES
dc.contributor.author Pérez-Ruiz, Raúl es_ES
dc.contributor.author Peñín, Beatriz es_ES
dc.contributor.author Sampedro, Diego es_ES
dc.contributor.author Caamaño, Antonio es_ES
dc.contributor.author de la Peña O Shea, Víctor A. es_ES
dc.date.accessioned 2022-11-07T19:01:56Z
dc.date.available 2022-11-07T19:01:56Z
dc.date.issued 2021-12 es_ES
dc.identifier.uri http://hdl.handle.net/10251/189396
dc.description.abstract [EN] Up-Conversion materials have received great attention in drug delivery applications in recent years. A specifically emerging field includes the development of strategies focusing on photon processes that promote the development of novel platforms for the efficient transport and the controlled release of drug molecules in the harsh microenvironment. Here, modified reaction time, thermal treatment, and pH conditions were controlled in the synthesis of NaYF4:Yb,Tm up-converted (UC) material to improve its photoluminescence properties. The best blue-emission performance was achieved for the UC3 sample prepared through 24 h-synthesis without thermal treatment at a pH of 5, which promotes the presence of the beta-phase and smaller particle size. NaYF4:Yb,Tm has resulted in a highly efficient blue emitter material for light-driven drug release under near-IR wavelength. Thus, NaYF4:Yb,Tm up-converted material promotes the N-O bond cleavage of the oxime ester of Ciprofloxacin (prodrug) as a highly efficient photosensitized drug delivery process. HPLC chromatography and transient absorption spectroscopy measurements were performed to evaluate the drug release conversion rate. UC3 has resulted in a very stable and easily recovered material that can be used in several reaction cycles. This straightforward methodology can be extended to other drugs containing photoactive chromophores and is present as an alternative for drug release systems. es_ES
dc.description.sponsorship This research was funded by the European Union's Horizon 2020 research and innovation program under European Research Council (ERC) through the HyMAP project, grant agreement No. 648319. Financial support was received from AEI-MICINN/FEDER, UE through the Nympha Project (PID2019-106315RB-I00). R.P.-R. thanks to the Generalitat Valenciana for financial support (CIDEGENT/2018/044). es_ES
dc.language Inglés es_ES
dc.publisher MDPI AG es_ES
dc.relation.ispartof Biomedicines es_ES
dc.rights Reconocimiento (by) es_ES
dc.subject Up-Conversion es_ES
dc.subject Drug-delivery es_ES
dc.subject Near IR-Light Therapy es_ES
dc.title Controlled Synthesis of Up-Conversion NaYF4:Yb,Tm Nanoparticles for Drug Release under Near IR-Light Therapy es_ES
dc.type Artículo es_ES
dc.identifier.doi 10.3390/biomedicines9121953 es_ES
dc.relation.projectID info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/PID2019-106315RB-I00/ES/MATERIALES HIBRIDOS NANOESTRUCTURADOS PARA LA PRODUCCION FOTOELECTROCATALITICA DE COMBUSTIBLES SOLARES/ es_ES
dc.relation.projectID info:eu-repo/grantAgreement/GENERALITAT VALENCIANA//CIDEGENT%2F2018%2F044//PHOTON UPCONVERSION REDOX CATALYSIS/ es_ES
dc.relation.projectID info:eu-repo/grantAgreement/EC/H2020/648319/EU es_ES
dc.rights.accessRights Abierto es_ES
dc.description.bibliographicCitation Moyano Rodríguez, E.; Gomez-Mendoza, M.; Pérez-Ruiz, R.; Peñín, B.; Sampedro, D.; Caamaño, A.; De La Peña O Shea, VA. (2021). Controlled Synthesis of Up-Conversion NaYF4:Yb,Tm Nanoparticles for Drug Release under Near IR-Light Therapy. Biomedicines. 9(12):1-13. https://doi.org/10.3390/biomedicines9121953 es_ES
dc.description.accrualMethod S es_ES
dc.relation.publisherversion https://doi.org/10.3390/biomedicines9121953 es_ES
dc.description.upvformatpinicio 1 es_ES
dc.description.upvformatpfin 13 es_ES
dc.type.version info:eu-repo/semantics/publishedVersion es_ES
dc.description.volume 9 es_ES
dc.description.issue 12 es_ES
dc.identifier.eissn 2227-9059 es_ES
dc.identifier.pmid 34944769 es_ES
dc.identifier.pmcid PMC8699023 es_ES
dc.relation.pasarela S\453080 es_ES
dc.contributor.funder European Commission es_ES
dc.contributor.funder GENERALITAT VALENCIANA es_ES
dc.contributor.funder Agencia Estatal de Investigación es_ES
dc.contributor.funder European Regional Development Fund es_ES


Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem